Search
BioLine RX Ltd
BLRXAdd to Watchlist
2.820USD
+0.100+3.72%
Close 07-31 16:00（ET）Quotes delayed by 15 min
12.27MMarket Cap
LossP/E TTM
More Details of BioLine RX Ltd Company
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
BioLine RX Ltd Info
Ticker SymbolBLRX
Company nameBioLine RX Ltd
IPO dateJan 30, 2007
CEOSerlin (Philip Adam)
Number of employees28
Security typeDepository Receipt
Fiscal year-endJan 30
AddressModi'in Technology Park
CityMODIIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryIsrael
Postal code7177871
Phone97286429100
Websitehttps://www.biolinerx.com/
Ticker SymbolBLRX
IPO dateJan 30, 2007
CEOSerlin (Philip Adam)
Company Executives of BioLine RX Ltd
Name
Name/Position
Position
Shareholding
Change
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Sandra Panem, Ph.D.
Dr. Sandra Panem, Ph.D.
Director
Director
--
--
Ms. Mali Zeevi
Ms. Mali Zeevi
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Hillit Mannor Shachar
Dr. Hillit Mannor Shachar
Vice President - Business Development
Vice President - Business Development
--
--
Dr. Ella Sorani
Dr. Ella Sorani
Vice President - Development
Vice President - Development
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Chairman of the Board
Chairman of the Board
--
--
Dr. Raphael (Rafi) Hofstein, Ph.D.
Dr. Raphael (Rafi) Hofstein, Ph.D.
Director
Director
--
--
Ms. Nurit Benjamini
Ms. Nurit Benjamini
External Director
External Director
--
--
Dr. Avraham (Avi) Molcho
Dr. Avraham (Avi) Molcho
External Director
External Director
--
--
Dr. Michael J. Anghel
Dr. Michael J. Anghel
Director
Director
--
--
Mr. Philip Adam (Phil) Serlin
Mr. Philip Adam (Phil) Serlin
Chief Executive Officer
Chief Executive Officer
--
--
FAQs
Who are the top five shareholders of BioLine RX Ltd?
The top five shareholders of BioLine RX Ltd are: Dr. Aharon Schwartz, Ph.D.
How many institutions hold shares of BioLine RX Ltd (BLRX)?
As of 2026Q1, 60 institutions hold shares of BioLine RX Ltd, with a combined market value of approximately 46.33K, accounting for 1.06% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -104547.00.